Nevertheless, this report was substantiated by Fatherree et al. [84], who recently demonstrated that chemotherapy-mediated upregulation of collagen IV in the mammary carcinoma ECM enhanced cancer cell motility in a Src- and focal-adhesion kinase (FAK)-dependent manner [84]. The gene discussed is PTK2; the disease is cancer.